Literature DB >> 19153733

One-day or two-day procedure for sentinel node biopsy in melanoma?

A H Chakera1, J Lock-Andersen, U Hesse, B M Nürnberg, B R Juhl, K H Stokholm, K T Drzewiecki, B Hesse.   

Abstract

PURPOSE: We compared the outcome of a 1-day and a 2-day sentinel node (SN) biopsy procedure, evaluated in terms of lymphoscintigraphic, surgical and pathological findings.
METHODS: We studied 476 patients with melanoma from two melanoma centres using static scintigraphy and blue dye. A proportional odds model was used for statistical analysis.
RESULTS: The number of SNs visualized at scintigraphy increased significantly with time from injection to scintigraphy and activity left in the patient at scintigraphy, and depended on the melanoma location. The number of SNs removed at surgery increased with the number of SNs visualized at scintigraphy and time from injection to surgery. The frequency of nodal metastasis increased with increasing thickness and Clark level of the melanoma, and was highest for two SNs visualized at scintigraphy.
CONCLUSION: This study showed that early vs. late imaging and surgery do make a difference on the outcome of the SN procedure and confirmed the importance of the scintigraphic visualization of all true SNs.

Entities:  

Mesh:

Year:  2009        PMID: 19153733     DOI: 10.1007/s00259-008-1036-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  27 in total

1.  The hidden sentinel node in breast cancer.

Authors:  P J Tanis; J W van Sandick; O E Nieweg; R A Valdés Olmos; E J T Rutgers; C A Hoefnagel; B B R Kroon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03       Impact factor: 9.236

2.  Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?

Authors:  K M McMasters; D S Reintgen; M I Ross; S L Wong; J E Gershenwald; D N Krag; R D Noyes; V Viar; P B Cerrito; M J Edwards
Journal:  Ann Surg Oncol       Date:  2001-04       Impact factor: 5.344

Review 3.  Radioguided sentinel lymph node biopsy in breast cancer surgery.

Authors:  G Mariani; L Moresco; G Viale; G Villa; M Bagnasco; G Canavese; J Buscombe; H W Strauss; G Paganelli
Journal:  J Nucl Med       Date:  2001-08       Impact factor: 10.057

4.  Sentinel node biopsy in cutaneous melanoma.

Authors:  Jørgen Lock-Andersen; Janne Horn; Helle Sjøstrand; Birgit Meinecke Nürnberg; Knud Heine Stokholm
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  2006

5.  Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage.

Authors:  R A Valdés Olmos; P J Tanis; C A Hoefnagel; O E Nieweg; S H Muller; E J Rutgers; M L Kooi; B B Kroon
Journal:  Nucl Med Commun       Date:  2001-05       Impact factor: 1.690

6.  Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma.

Authors:  R F Uren; R Howman-Giles; J F Thompson; H M Shaw; M J Quinn; C J O'Brien; W H McCarthy
Journal:  Melanoma Res       Date:  1994-12       Impact factor: 3.599

7.  The development of optimal pathological assessment of sentinel lymph nodes for melanoma.

Authors:  Martin G Cook; Margaret A Green; Brian Anderson; Alexander M M Eggermont; Dirk J Ruiter; Alain Spatz; Mark W Kissin; Barry W E M Powell
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

8.  Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision.

Authors:  Helene Nortvig Abrahamsen; Stephen J Hamilton-Dutoit; Jørn Larsen; Torben Steiniche
Journal:  Cancer       Date:  2004-04-15       Impact factor: 6.860

9.  Sentinel node detection using 99mTc-rhenium sulphide colloid in breast cancer patients: evaluation of 1 day and 2 day protocols, and a dose-finding study.

Authors:  M Koizumi; E Nomura; Y Yamada; T Takiguchi; K Tanaka; M Yoshimoto; M Makita; G Sakamoto; F Kasumi; E Ogata
Journal:  Nucl Med Commun       Date:  2003-06       Impact factor: 1.690

Review 10.  New TNM melanoma staging system: linking biology and natural history to clinical outcomes.

Authors:  Charles M Balch; Antonio C Buzaid; Seng-Jaw Soong; Michael B Atkins; Natale Cascinelli; Daniel G Coit; Irvin D Fleming; Jeffrey E Gershenwald; Alan Houghton; John M Kirkwood; Kelly M McMasters; Martin F Mihm; Donald L Morton; Douglas S Reintgen; Merrick I Ross; Arthur Sober; John A Thompson; John F Thompson
Journal:  Semin Surg Oncol       Date:  2003
View more
  2 in total

1.  EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.

Authors:  Annette H Chakera; Birger Hesse; Zeynep Burak; James R Ballinger; Allan Britten; Corrado Caracò; Alistair J Cochran; Martin G Cook; Krzysztof T Drzewiecki; Richard Essner; Einat Even-Sapir; Alexander M M Eggermont; Tanja Gmeiner Stopar; Christian Ingvar; Martin C Mihm; Stanley W McCarthy; Nicola Mozzillo; Omgo E Nieweg; Richard A Scolyer; Hans Starz; John F Thompson; Giuseppe Trifirò; Giuseppe Viale; Sergi Vidal-Sicart; Roger Uren; Wendy Waddington; Arturo Chiti; Alain Spatz; Alessandro Testori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

2.  EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

Authors:  Christina Bluemel; Ken Herrmann; Francesco Giammarile; Omgo E Nieweg; Julien Dubreuil; Alessandro Testori; Riccardo A Audisio; Odysseas Zoras; Michael Lassmann; Annette H Chakera; Roger Uren; Sotirios Chondrogiannis; Patrick M Colletti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-25       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.